These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 33337841)
41. The clinical aspects of biclonal gammopathies. Review of 57 cases. Kyle RA; Robinson RA; Katzmann JA Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297 [TBL] [Abstract][Full Text] [Related]
42. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807 [TBL] [Abstract][Full Text] [Related]
43. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal]. Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201 [TBL] [Abstract][Full Text] [Related]
44. Is this a true lambda free light chain? Volovik Y; Nimri-Ammouri S; Adler T; Barak M; Henig C Clin Chem Lab Med; 2023 Jan; 61(2):e36-e37. PubMed ID: 36351252 [No Abstract] [Full Text] [Related]
45. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572 [TBL] [Abstract][Full Text] [Related]
46. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232 [TBL] [Abstract][Full Text] [Related]
47. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease. Levinson SS Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046 [TBL] [Abstract][Full Text] [Related]
48. Differences identified between serum and urine immunofixation electrophoresis. Tracy E; Andrews DM; Constantin MA; Zhu Y Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209 [TBL] [Abstract][Full Text] [Related]
49. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [TBL] [Abstract][Full Text] [Related]
50. The evolving use of serum free light chain assays in haematology. Pratt G Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757 [TBL] [Abstract][Full Text] [Related]
51. Biclonal IgA and IgM gammopathy in lymphocytic lymphoma. Weinstein S; Jain A; Bhagavan NV; Scottolini AG Clin Chem; 1984 Oct; 30(10):1710-2. PubMed ID: 6434203 [TBL] [Abstract][Full Text] [Related]
53. Patient-specific microheterogeneity patterns of monoclonal immunoglobulin light chains as revealed by high resolution, two-dimensional electrophoresis. Harrison HH Clin Biochem; 1992 Aug; 25(4):235-43. PubMed ID: 1525978 [TBL] [Abstract][Full Text] [Related]
54. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias. Levinson SS Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799 [TBL] [Abstract][Full Text] [Related]